French Public Health Law

The Code de la Santé Publique

French public health law is codified in the Code de la santé publique (CSP), a comprehensive legislative text covering the organisation of the health system, the regulation of healthcare professions, patient rights, public health emergencies, and health product safety. The CSP is divided into six parts: (1) general protection of health; (2) health professions; (3) health products and pharmaceuticals; (4) health administration and establishments; (5) health products regulation; and (6) overseas territories.

The CSP is supplemented by the Code de la sécurité sociale (health insurance and social protection) and the Code de l’action sociale et des familles (social care). The Haut Conseil de la Santé Publique (HCSP) provides scientific advice to the government on public health policy, including vaccination strategies, disease prevention, and health crisis management.

The Haute Autorité de Santé (HAS)

The Haute Autorité de Santé (HAS) is an independent public authority with broad responsibilities for quality and safety in healthcare. Established by Law No. 2004-806 of 9 August 2004 (the Loi relative à la politique de santé publique), the HAS evaluates the clinical and economic effectiveness of health products and services, develops clinical practice guidelines (recommandations de bonne pratique), and accredits healthcare organisations.

The HAS’s assessment of health products (medicines, medical devices, diagnostic tests) determines their eligibility for reimbursement by the national health insurance system. The HAS also evaluates the quality of care in public and private hospitals, publishes performance indicators, and administers the certification of healthcare professionals. Its decisions are subject to appeal before the Conseil d’État.

Agences Régionales de Santé (ARS)

The Agences Régionales de Santé (ARS) are the regional public health authorities created by the Loi Hôpital, Patients, Santé et Territoires (Law No. 2009-879 of 21 July 2009, the Loi HPST). There are 18 ARS (including overseas territories), each responsible for coordinating public health policy, regulating healthcare provision, and managing the regional health budget.

The ARS have broad regulatory powers, including the authority to license healthcare establishments, approve medical equipment investments, allocate regional health funding, and impose quality standards. The ARS also manage public health emergencies at the regional level, including infectious disease outbreaks, natural disasters, and environmental health hazards. The Conseil d’État in Decision No. 428975 (2020) held that the ARS’s decisions on hospital closures and service reconfigurations must be based on objective health needs assessments and must respect patient access to care.

French Hospital Law and T2A

Hospital law is governed by Articles L. 6111-1 to L. 6162-19 CSP, which establish the legal framework for public hospitals (établissements publics de santé), private non-profit hospitals (établissements privés d’intérêt collectif), and private for-profit clinics. Public hospitals have a public service mission (service public hospitalier) that includes emergency care, medical education, research, and health promotion.

The tarification à l’activité (T2A, activity-based funding) was introduced by the Loi HPST (2009) as the primary funding model for hospitals. Under T2A, hospitals are reimbursed for each medical procedure performed, calculated according to a national pricing schedule (Groupe Homogène de Séjour — GHS). The T2A system has been criticised for incentivising volume over quality, leading to subsequent reforms that include quality-based payments (incitation financière à l’amélioration de la qualité — IFEQ) and population health funding for certain categories of care.

The Loi de financement de la sécurité sociale (LFSS) sets the annual hospital budget and determines the parameters of the T2A system. The hospital sector has undergone significant consolidation, with the creation of Groupements Hospitaliers de Territoire (GHTs) under the Loi de modernisation de notre système de santé (Law No. 2016-41 of 26 January 2016), requiring public hospitals within the same region to cooperate in clinical and administrative functions.

Public Health Emergencies

France has a robust legal framework for public health emergencies, tested and refined during the COVID-19 pandemic. The Code de la santé publique (Articles L. 3131-1 to L. 3131-24) empowers the Minister of Health to take emergency measures in the event of a serious health threat, including isolation, quarantine, and restrictions on movement. The Loi relative à la gestion de la crise sanitaire (Law No. 2022-46 of 22 January 2022) codified the state of health emergency (état d’urgence sanitaire), which may be declared by decree of the Council of Ministers for a maximum of one month, renewable with parliamentary approval.

The Conseil constitutionnel in Decision No. 2020-800 DC (11 May 2020) reviewed the constitutionality of the emergency health measures, upholding the framework subject to safeguards including proportionality review by the Conseil d’État and parliamentary oversight. The Conseil d’État in Decision No. 449095 (2021) held that travel restrictions during the pandemic were lawful but required the government to provide a substantive justification based on epidemiological data.

Vaccine Mandates and Prevention

France has one of the most comprehensive vaccination frameworks in Europe. Articles L. 3111-1 to L. 3111-4 CSP make eleven vaccines mandatory for children (including DTP, measles, mumps, rubella, polio, hepatitis B, and meningococcus C), introduced by the Loi de modernisation de notre système de santé (2016). The Conseil d’État in Decision No. 420886 (2018) upheld the mandatory vaccination regime, rejecting arguments that it infringed bodily integrity or personal autonomy.

The Haut Conseil de la Santé Publique issues the vaccination schedule and recommends additional vaccines for specific populations, including healthcare workers and pregnant women. The Loi Climat et Résilience (2021) integrated health prevention into climate adaptation planning, recognising the public health impacts of climate change and the need for health system preparedness.